Memorial Sloan Kettering Cancer Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).

1,884 total trials 327 currently recruiting 1104 completed early-phase tilt top decile by trial count

Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.

Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.

Top-decile sponsor footprint

Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,884 total, page 31 of 38

COMPLETED

Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer

NCT00579683
COMPLETED

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

NCT00132704
COMPLETED

Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

NCT00579293
COMPLETED NA

Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors

NCT00598741
COMPLETED Phase 2

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

NCT00096525
COMPLETED NA

An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery

NCT00597454
COMPLETED Phase 3

Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial

NCT00200096
COMPLETED Phase 2

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

NCT00089258
COMPLETED

Adolescent Survivors of Cancer or Similar Illnesses

NCT00579631
COMPLETED

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging

NCT00612326
COMPLETED Early Phase 1

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

NCT00620243
COMPLETED NA

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

NCT00606294
COMPLETED Phase 2

Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

NCT00087282
COMPLETED Phase 2

Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

NCT00588445
COMPLETED Phase 2

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

NCT00587964
COMPLETED Phase 1

Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

NCT00096486
COMPLETED

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

NCT00578409
TERMINATED Phase 1

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

NCT00087009
COMPLETED Phase 2

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

NCT00255723
COMPLETED NA

Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification

NCT00582959
COMPLETED NA

Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

NCT00096538
COMPLETED Phase 1

Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00084812
COMPLETED

Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer

NCT00582387
COMPLETED Phase 3

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

NCT00200148
COMPLETED Phase 1

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

NCT00588003
COMPLETED Phase 1

Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors

NCT00084786
COMPLETED NA

Internet-based System for Cancer Patients to Self-report Toxicity

NCT00578006
COMPLETED Phase 1

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

NCT00085566
COMPLETED NA

The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules

NCT00598065
COMPLETED NA

Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer

NCT00084773
COMPLETED

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

NCT00580203
COMPLETED NA

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

NCT00199862
COMPLETED

Prospective Study Assessing Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Removal of the Cervix Versus Removal of the Uterus,Ovaries and Fallopian Tubes For Treatment Of Early Stage Cervical Cancer

NCT00579787
COMPLETED Phase 2

Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate

NCT00081172
COMPLETED Early Phase 1

Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity

NCT00580060
COMPLETED Phase 1

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT00081133
COMPLETED Phase 2

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy

NCT00081107
TERMINATED Phase 2

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

NCT00195091
COMPLETED NA

Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound

NCT00597610
COMPLETED Phase 1

Vaccine Therapy in Treating Patients With Kidney Cancer

NCT00096629
COMPLETED Phase 3

Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer

NCT00090337
COMPLETED Phase 3

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

NCT00138112
COMPLETED

Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

NCT00578630
COMPLETED Phase 2

Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

NCT00074009
COMPLETED Phase 2

Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer

NCT00077259
COMPLETED Phase 2

Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL

NCT00588094
COMPLETED Phase 1

ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer

NCT00077246
COMPLETED Phase 3

Acupuncture For Pancreatic Cancer Pain

NCT00136669
COMPLETED

Health Communication in Families

NCT00597961
COMPLETED Phase 2

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

NCT00070096
← Previous Page 31 of 38 Next →

Phase Distribution

PhaseTrial count
Phase 1 461
Phase 2 640
Phase 3 67
Phase 4 8

Therapeutic Areas

Breast Cancer 98
Prostate Cancer 53
Lung Cancer 36
Multiple Myeloma 34
Lymphoma 34
Ovarian Cancer 31
Leukemia 30
Sarcoma 26
Colorectal Cancer 22
Cancer 22

What is open in the Memorial Sloan Kettering Cancer Center pipeline

327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).

Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).

Top condition: Breast Cancer (98 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.